1. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51:676–85. [PubMed] [Google Scholar]
2. Devous MD Sr, Thisted RA, Morgan GF, Leroy RF, Rowe CC. SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med. 1998;39:285–93. [PubMed] [Google Scholar]
3. Spencer SS. The relative contributions of MRI SPECT and PET imaging in epilepsy. Epilepsia. 1994;35:S72–S89. [PubMed] [Google Scholar]
4. Weil S, Noachtar S, Arnold S, Yousry TA, Winkler PA, Tatsch K. Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control. Nucl Med Commun. 2001;22:233–7. [PubMed] [Google Scholar]
5. Society of Nuclear Medicine Procedure Guideline for FDG PET Brain Imaging Version 1.0. approved February 8, 2009. [Google Scholar]
6. Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K European Association of Nuclear Medicine Neuroimaging Committee. EANM procedure guidelines for PET brain imaging using [18F] FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103–10. [PubMed] [Google Scholar]
7. Stanescu L, Ishak GE, Khanna PC, Biyyam DR, Shaw DW, Parisi MT. FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation. Radiographics. 2013;33:1279–303. [PubMed] [Google Scholar]
8. Chugani HT, Phelps ME. Imaging human brain development with positron emission tomography. J Nucl Med. 1991;32:23–6. [PubMed] [Google Scholar]
9. Kennedy C, Sokoloff L. An adaptation of the nitrous oxide method to the study of the cerebral circulation in children: normal values for cerebral blood flow and cerebral metabolic rate in childhood. J Clin Invest. 1957;36:1130–1137. [PMC free article] [PubMed] [Google Scholar]
10. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, Schönknecht P, Ito K, Mielke R, Kalbe E, Zündorf G, Delbeuck X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Desgranges B, Eustache F, Beuthien-Baumann B, Menzel C, Schröder J, Kato T, Arahata Y, Henze M, Heiss WD. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17:302–16. [PubMed] [Google Scholar]
11. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med. 1995;36:1141–9. [PubMed] [Google Scholar]
12. Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Mandel F, Alexander GE, Grady C, Pietrini P, Eidelberg D. The metabolic topography of normal aging. J Cereb Blood Flow Metab. 1996;16:385–98. [PubMed] [Google Scholar]
13. Ferrie CD, Marsden PK, Maisey MN, Robinson RO. Visual and semiquantitative analysis of cortical FDG-PET scans in childhood epileptic encephalopathies. J Nucl Med. 1997;38:1891–4. [PubMed] [Google Scholar]
14. Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, Römer W, Tatsch K, Weber W, Bartenstein P. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med. 1999;40:737–46. [PubMed] [Google Scholar]
15. Hikima A, Mochizuki H, Oriuchi N, Endo K, Morikawa A. Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy. Ann Nucl Med. 2004;18:579–84. [PubMed] [Google Scholar]
16. Won HJ, Chang KH, Cheon JE, Kim HD, Lee DS, Han MH, Kim IO, Lee SK, Chung CK. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol. 1999;20:593–9. [PMC free article] [PubMed] [Google Scholar]
17. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH. FDGPET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology. 1995;45:123–126. [PubMed] [Google Scholar]
18. Knowlton RC, Laxer KD, Ende G, Hawkins RA, Wong ST, Matson GB, Rowley HA, Fein G, Weiner MW. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol. 1997;42:829–837. [PMC free article] [PubMed] [Google Scholar]
19. Kim YK, Lee DS, Lee SK, Chung CK, Chung JK, Lee MC. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002;43:1167–74. [PubMed] [Google Scholar]
20. Theodore WH, Sato S, Kufta CV, Gaillard WD, Kelley K. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia. 1997;38:81–6. [PubMed] [Google Scholar]
21. Gok B, Jallo G, Hayeri R, Wahl R, Aygun N. The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy. Neuroradiology. 2013;55:541–50. [PubMed] [Google Scholar]
22. Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res. 2014;108:1306–14. [PubMed] [Google Scholar]
23. da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia. 1997;38:1198–208. [PubMed] [Google Scholar]
24. Leiderman DB, Balish M, Sato S, Kufta C, Reeves P, Gaillard WD, Theodore WH. Comparison of PET measurements of cerebral blood flow and glucose metabolism for the localization of human epileptic foci. Epilepsy Res. 1992;13:153–7. [PubMed] [Google Scholar]
25. Fink GR, Pawlik G, Stefan H, Pietrzyk U, Wienhard K, Heiss WD. Temporal lobe epilepsy: evidence for interictal uncoupling of blood flow and glucose metabolism in temporomesial structures. J Neurol Sci. 1996;137:28–34. [PubMed] [Google Scholar]
26. Zubal IG, Avery RA, Stokking R, Studholme C, Corsi M, Dey H, Seibyl JP, Spencer SS. Ratioimages calculated from interictal positron emission tomography and single-photon emission computed tomography for quantification of the uncoupling of brain metabolism and perfusion in epilepsy. Epilepsia. 2000;41:1560–6. [PubMed] [Google Scholar]
27. Buch K, Blumenfeld H, Spencer S, Novotny E, Zubal IG. Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization. Eur J Nucl Med Mol Imaging. 2008;35:579–88. [PubMed] [Google Scholar]
28. Ho SS, Berkovic SF, Berlangieri SU, Newton MR, Egan GF, Tochon-Danguy HJ, McKay WJ. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol. 1995;37:738–45. [PubMed] [Google Scholar]
29. Bouilleret V, Valenti MP, Hirsch E, Semah F, Namer IJ. Correlation between PET and SISCOM in temporal lobe epilepsy. J Nucl Med. 2002;43:991–8. [PubMed] [Google Scholar]
30. Hwang SI, Kim JH, Park SW, Han MH, Yu IK, Lee SH, Lee DS, Lee SK, Chung CK, Chang KH. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy. Am J Neuroradiol. 2001;22:937–46. [PMC free article] [PubMed] [Google Scholar]
31. Desai A, Bekelis K, Thadani VM, Roberts DW, Jobst BC, Duhaime AC, Gilbert K, Darcey TM, Studholme C, Siegel A. Interictal PET and ictal subtraction SPECT: sensitivity in the detection of seizure foci in patients with medically intractable epilepsy. Epilepsia. 2013;54:341–50. [PubMed] [Google Scholar]
32. Perissinotti A, Setoain X, Aparicio J, Rubí S, Fuster BM, Donaire A, Carreño M, Bargalló N, Rumiá J, Garcia-Fructuoso G, Mayoral M, Sanmartí F, Pons F. Clinical Role of Subtraction Ictal SPECT Coregistered to MR Imaging and 18F-FDG PET in Pediatric Epilepsy. J Nucl Med. 2014;55:1099–1105. [PubMed] [Google Scholar]
33. Murphy MA, O’Brien TJ, Morris K, Cook MJ. Multimodality image-guided surgery for the treatment of medically refractory epilepsy. J Neurosurg. 2004;100:452–62. [PubMed] [Google Scholar]
34. Lee KK, Salamon N. [18F] fluorodeoxyglucose-positron-emission tomography and MR imaging coregistration for presurgical evaluation of medically refractory epilepsy. AJNR Am J Neuroradiol. 2009;30:1811–6. [PMC free article] [PubMed] [Google Scholar]
35. Radtke RA, Hanson MW, Hoffman JM, Crain BJ, Walczak TS, Lewis DV, Beam C, Coleman RE, Friedman AH. Temporal lobe hypometabolism on PET: Predictor of seizure control after temporal lobectomy. Neurology. 1993;43:1088–1092. [PubMed] [Google Scholar]
36. Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography. Ann Neurol. 1992;32:789–794. [PubMed] [Google Scholar]
37. Manno EM, Sperling MR, Ding X, Jaggi J, Alavi A, O’Connor MJ, Reivich M. Predictors of outcome after anterior temporal lobectomy: Positron emission tomography. Neurology. 1994;44:2331–2336. [PubMed] [Google Scholar]
38. Swartz BE, Tomiyasu U, Delgado-Escueta AV, Mandelkern M, Khonsari A. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and post-surgical outcome. Epilepsia. 1992;33:624–634. [PubMed] [Google Scholar]
39. Blum DE, Ehsan T, Dungan D, Karis JP, Fisher RS. Bilateral temporal hypometabolism in epilepsy. Epilepsia. 1998;39:651–659. [PubMed] [Google Scholar]
40. Willmann O, Wennberg R, May T, Woermann FG, Pohlmann-Eden B. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis. Seizure. 2007;16:509–20. [PubMed] [Google Scholar]
41. Siclari F, Prior JO, Rossetti AO. Ictal cerebral positron emission tomography (PET) in focal status epilepticus. Epilepsy Res. 2013;105:356–61. [PubMed] [Google Scholar]
42. Stayman A, Abou-Khalil B. FDG-PET in the diagnosis of complex partial status epilepticus originating from the frontal lobe. Epilepsy Behav. 2011;20:721–4. [PubMed] [Google Scholar]
43. Dong C, Sriram S, Delbeke D, Al-Kaylani M, Arain AM, Singh P, McLean MJ, Abou-Khalil B. Aphasic or amnesic status epilepticus detected on PET but not EEG. Epilepsia. 2009;50:251–5. [PubMed] [Google Scholar]
44. Mehta AD, Ettinger AB, Perrine K, Dhawan V, Patil A, Jain SK, Klein G, Schneider SJ, Eidelberg D. Seizure propagation in a patient with musicogenic epilepsy. Epilepsy Behav. 2009;14:421–4. [PubMed] [Google Scholar]
45. Fong CY, Delgado-Escueta AV. Ictal PET in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 1999;67:409. [PMC free article] [PubMed] [Google Scholar]
46. Chugani HT, Shewmon DA, Khanna S, Phelps ME. Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol. 1993;9:10–5. [PubMed] [Google Scholar]
47. Leiderman DB, Albert P, Balish M, Bromfield E, Theodore WH. The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F 18. Arch Neurol. 1994;51:932–6. [PubMed] [Google Scholar]
48. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging. 2003;30:581–7. [PubMed] [Google Scholar]
49. Tepmongkol S, Srikijvilaikul T, Vasavid P. Factors affecting bilateral temporal lobe hypometabolism on 18F-FDG PET brain scan in unilateral medial temporal lobe epilepsy. Epilepsy Behav. 2013;29:386–9. [PubMed] [Google Scholar]
50. Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology. 1994;44:S14–23. [PubMed] [Google Scholar]
51. Chapman AG. Glutamate and epilepsy. J Nutr. 2000;130:1043S–5S. [PubMed] [Google Scholar]
52. Chagnac-Amitai Y, Connors BW. Horizontal spread of synchronized activity in neocortex and its control by GABA-mediated inhibition. J Neurophysiol. 1989;61:747–758. [PubMed] [Google Scholar]
53. Tortella FC, Echevarria E, Robles L, Mosberg HI, Holaday JW. Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Peptides. 1988;9:1177–81. [PubMed] [Google Scholar]
54. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J Neurochem. 2004;89:834–43. [PubMed] [Google Scholar]
55. Bozzi Y, Dunleavy M, Henshall DC. Cell signaling underlying epileptic behavior. Front Behav Neurosci. 2011;5:45. [PMC free article] [PubMed] [Google Scholar]
56. Starr MS. The role of dopamine in epilepsy. Synapse. 1996;22:159–94. [PubMed] [Google Scholar]
57. Masino SA, Kawamura M Jr, Ruskin DN. Adenosine receptors and epilepsy: current evidence and future potential. Int Rev Neurobiol. 2014;119:233–55. [PMC free article] [PubMed] [Google Scholar]
58. Savic I, Ingvar M, Stone-Elander S. Comparison of [11C] flumazenil and [18F] FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry. 1993;56:615–21. [PMC free article] [PubMed] [Google Scholar]
59. Savic I, Thorell JO, Roland P. [11C] flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia. 1995;36:1225–32. [PubMed] [Google Scholar]
60. Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, Sackellares JC, Albin RL. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 1995;45:934–41. [PubMed] [Google Scholar]
61. Szelies B, Weber-Luxenburger G, Pawlik G, Kessler J, Holthoff V, Mielke R, Herholz K, Bauer B, Wienhard K, Heiss WD. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage. 1996;3:109–18. [PubMed] [Google Scholar]
62. Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, Bouilleret V, Myers DE, Cook MJ, Hicks RJ, O’Brien TJ. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. J Nucl Med. 2013;54:1270–7. [PubMed] [Google Scholar]
63. Koepp MJ, Richardson MP, Labbé C, Brooks DJ, Cunningham VJ, Ashburner J, Van Paesschen W, Revesz T, Duncan JS. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology. 1997;49:764–73. [PubMed] [Google Scholar]
64. Muzik O, da Silva EA, Juhasz C, Chugani DC, Shah J, Nagy F, Canady A, von Stockhausen HM, Herholz K, Gates J, Frost M, Ritter F, Watson C, Chugani HT. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology. 2000;54:171–9. [PubMed] [Google Scholar]
65. Ryvlin P, Bouvard S, Le Bars D, De Lamérie G, Grégoire MC, Kahane P, Froment JC, Mauguière F. Clinical utility of flumazenil-PET versus [18F] fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain. 1998;121:2067–81. [PubMed] [Google Scholar]
66. Yankam Njiwa J, Bouvard S, Catenoix H, Mauguiere F, Ryvlin P, Hammers A. Periventricular [(11)C] flumazenil binding for predicting postoperative outcome in individual patients with temporal lobe epilepsy and hippocampal sclerosis. Neuroimage Clin. 2013;3:242–8. [PMC free article] [PubMed] [Google Scholar]
67. Hammers A, Koepp MJ, Brooks DJ, Duncan JS. Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis. Epilepsia. 2005;46:944–8. [PubMed] [Google Scholar]
68. Savic I, Widen L, Thorell JO, Blomqvist G, Ericson K, Roland P. Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia. 1990;31:724–30. [PubMed] [Google Scholar]
69. Frost JJ, Mayberg HS, Fisher RS, Douglass KH, Dannals RF, Links JM, Wilson AA, Ravert HT, Rosenbaum AE, Snyder SH, et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol. 1988;23:231–7. [PubMed] [Google Scholar]
70. Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol. 1997;41:358–67. [PubMed] [Google Scholar]
71. Mayberg HS, Sadzot B, Meltzer CC, Fisher RS, Lesser RP, Dannals RF, Lever JR, Wilson AA, Ravert HT, Wagner HN Jr. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 1991;30:3–11. [PubMed] [Google Scholar]
72. Prevett MC, Cunningham VJ, Brooks DJ, Fish DR, Duncan JS. Opiate receptors in idiopathic generalised epilepsy measured with [11C] diprenorphine and positron emission tomography. Epilepsy Res. 1994;19:71–7. [PubMed] [Google Scholar]
73. Bartenstein PA, Prevett MC, Duncan JS, Hajek M, Wieser HG. Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography. Epilepsy Res. 1994;18:119–25. [PubMed] [Google Scholar]
74. Hammers A, Asselin MC, Hinz R, Kitchen I, Brooks DJ, Duncan JS, Koepp MJ. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain. 2007;130:1009–16. [PubMed] [Google Scholar]
75. McGinnity CJ, Shidahara M, Feldmann M, Keihaninejad S, Riaño Barros DA, Gousias IS, Duncan JS, Brooks DJ, Heckemann RA, Turkheimer FE, Hammers A, Koepp MJ. Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C] diprenorphine PET data for the partial-volume effect. Neuroimage. 2013;79:72–80. [PubMed] [Google Scholar]
76. Bartenstein PA, Duncan JS, Prevett MC, Cunningham VJ, Fish DR, Jones AK, Luthra SK, Sawle GV, Brooks DJ. Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatry. 1993;56:1295–302. [PMC free article] [PubMed] [Google Scholar]
77. Koepp MJ, Richardson MP, Brooks DJ, Duncan JS. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet. 1998;352:952–5. [PubMed] [Google Scholar]
78. Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, Fazilat S, Kopylev L, Herscovitch P, Eckelman WC, Theodore WH. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. 2003;60:749–56. [PubMed] [Google Scholar]
79. Merlet I, Ostrowsky K, Costes N, Ryvlin P, Isnard J, Faillenot I, Lavenne F, Dufournel D, Le Bars D, Mauguière F. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F] MPPF-PET study. Brain. 2004;127:900–13. [PubMed] [Google Scholar]
80. Savic I, Lindström P, Gulyás B, Halldin C, Andrée B, Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. 2004;62:1343–51. [PubMed] [Google Scholar]
81. Merlet I, Ryvlin P, Costes N, Dufournel D, Isnard J, Faillenot I, Ostrowsky K, Lavenne F, Le Bars D, Mauguière F. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage. 2004;22:886–96. [PubMed] [Google Scholar]
82. Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, Reeves-Tyer P, Herscovitch P, Eckelman WC, Carson RE, Theodore WH. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med. 2005;46:1128–35. [PMC free article] [PubMed] [Google Scholar]
83. Ito S, Suhara T, Ito H, Yasuno F, Ichimiya T, Takano A, Maehara T, Matsuura M, Okubo Y. Changes in central 5-HT(1A) receptor binding in mesial temporal epilepsy measured by positron emission tomography with [(11)C] WAY100635. Epilepsy Res. 2007;73:111–8. [PubMed] [Google Scholar]
84. Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Mauguière F. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain. 2008;131:2751–64. [PubMed] [Google Scholar]
85. Liew CJ, Lim YM, Bonwetsch R, Shamim S, Sato S, Reeves-Tyer P, Herscovitch P, Dustin I, Bagic A, Giovacchini G, Theodore WH. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy. Epilepsia. 2009;50:234–9. [PMC free article] [PubMed] [Google Scholar]
86. Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien LK, Stögmann E, Baumgartner C, Kletter K, Asenbaum S. Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C] WAY-100635 PET study. Epilepsy Behav. 2010;19:467–73. [PubMed] [Google Scholar]
87. Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, Drevets W. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia. 2007;48:1526–30. [PubMed] [Google Scholar]
88. Martinez A, Finegersh A, Cannon DM, Dustin I, Nugent A, Herscovitch P, Theodore WH. The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy. Neurology. 2013;80:1465–71. [PMC free article] [PubMed] [Google Scholar]
89. Cuellar-Herrera M, Velasco AL, Velasco F, Trejo D, Alonso-Vanegas M, Nuche-Bricaire A, Vázquez-Barrón D, Guevara-Guzmán R, Rocha L. Alterations of 5-HT1A receptor-induced G-protein functional activation and relationship to memory deficits in patients with pharmacoresistant temporal lobe epilepsy. Epilepsy Res. 2014;108:1853–63. [PubMed] [Google Scholar]
90. Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F] fallypride PET study. Epilepsia. 2006;47:1392–6. [PubMed] [Google Scholar]
91. Landvogt C, Buchholz HG, Bernedo V, Schreckenberger M, Werhahn KJ. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy. Epilepsia. 2010;51:1699–706. [PubMed] [Google Scholar]
92. Choi H, Kim YK, Oh SW, Im HJ, Hwang do W, Kang H, Lee B, Lee YS, Jeong JM, Kim EE, Chung JK, Lee DS. In vivo imaging of mGluR5 changes during epileptogenesis using [11C] ABP688 PET in pilocarpine-induced epilepsy rat model. PLoS One. 2014;9:e92765. [PMC free article] [PubMed] [Google Scholar]
93. Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schöllhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 2006;129:2047–60. [PubMed] [Google Scholar]
94. Dupont S, Semah F, Loc’h C, Strijckmans V, Baulac M, Samson Y, Mazière B. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br] 4-bromodexetimide. J Nucl Med. 1999;40:935–41. [PubMed] [Google Scholar]
95. Kumlien E, Hartvig P, Valind S, Oye I, Tedroff J, Långström B. NMDA-receptor activity visualized with (S)-[N-methyl-11C] ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia. 1999;40:30–7. [PubMed] [Google Scholar]
96. Rubí S, Costes N, Heckemann RA, Bouvard S, Hammers A, Martí Fuster B, Ostrowsky K, Montavont A, Jung J, Setoain X, Catenoix H, Hino K, Liger F, Le Bars D, Ryvlin P. Positron emission tomography with α-[11C] methyl-Ltryptophan in tuberous sclerosis complex-related epilepsy. Epilepsia. 2013;54:2143–50. [PubMed] [Google Scholar]
97. Fedi M, Reutens DC, Andermann F, Okazawa H, Boling W, White C, Dubeau F, Nakai A, Gross DW, Andermann E, Diksic M. alpha-[11C] -Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res. 2003;52:203–13. [PubMed] [Google Scholar]
98. Natsume J, Kumakura Y, Bernasconi N, Soucy JP, Nakai A, Rosa P, Fedi M, Dubeau F, Andermann F, Lisbona R, Bernasconi A, Diksic M. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology. 2003;60:756–61. [PubMed] [Google Scholar]
99. Wakamoto H, Chugani DC, Juhász C, Muzik O, Kupsky WJ, Chugani HT. Alpha-methyl-ltryptophan positron emission tomography in epilepsy with cortical developmental malformations. Pediatr Neurol. 2008;39:181–8. [PubMed] [Google Scholar]
100. Chugani DC, Chugani HT, Muzik O, Shah JR, Shah AK, Canady A, Mangner TJ, Chakraborty PK. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C] methyl-L-tryptophan positron emission tomography. Ann Neurol. 1998;44:858–66. [PubMed] [Google Scholar]
101. Chugani DC. α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions. Biomark Med. 2011;5:567–75. [PMC free article] [PubMed] [Google Scholar]
102. Juhász C, Chugani DC, Muzik O, Shah A, Asano E, Mangner TJ, Chakraborty PK, Sood S, Chugani HT. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology. 2003;60:960–8. [PubMed] [Google Scholar]
103. Tatlidil R, Xiong J, Luther S. Presurgical lateralization of seizure focus and language dominant hemisphere with O-15 water PET imaging. Acta Neurol Scand. 2000;102:73–80. [PubMed] [Google Scholar]
104. Tatlidil R, Luther S, West A, Jadvar H, Kingman T. Comparison of fluorine-18 deoxyglucose and O-15 water PET in temporal lobe epilepsy. Acta Neurol Belg. 2000;100:214–20. [PubMed] [Google Scholar]
105. Henry TR, Votaw JR, Pennell PB, Epstein CM, Bakay RA, Faber TL, Grafton ST, Hoffman JM. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology. 1999;52:1166–73. [PubMed] [Google Scholar]
106. Franck G, Sadzot B, Salmon E, Depresseux JC, Grisar T, Peters JM, Guillaume M, Quaglia L, Delfiore G, Lamotte D. Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus. Adv Neurol. 1986;44:935–48. [PubMed] [Google Scholar]
107. Bernardi S, Trimble MR, Frackowiak RS, Wise RJ, Jones T. An interictal study of partial epilepsy using positron emission tomography and the oxygen - 15 inhalation technique. J Neurol Neurosurg Psychiatry. 1983;46:473–7. [PMC free article] [PubMed] [Google Scholar]
108. Sone D, Ito K, Taniguchi G, Murata Y, Nakata Y, Watanabe Y, Okazaki M, Sato N, Matsuda H, Watanabe M. Evaluation of amygdala pathology using (11)C-methionine positron emission tomography/computed tomography in patients with temporal lobe epilepsy and amygdala enlargement. Epilepsy Res. 2015;112:114–21. [PubMed] [Google Scholar]
109. Sasaki M, Kuwabara Y, Yoshida T, Fukumura T, Morioka T, Nishio S, Fukui M, Masuda K. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. J Nucl Med. 1998;39:974–7. [PubMed] [Google Scholar]